Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Quizlet guillain barre
Anatomy and physiology of guillain barre syndrome
Quizlet guillain barre
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Quizlet guillain barre
This paper will discuss what Guillain-Barre Syndrome is. It will also discuss what causes Guillain-Barre Syndrome and how to treat it. This paper will go into detail about the pathophysiology of GBS. The information in this paper was gathered from the Williams/Hopper book used for the nursing program and an article titled “Recent developments and future directions in Guillain-Barre syndrome” written by Helmar C Lehmann Richard A.C. Hughes, Bernd C Kieseier, and Hans-Peter Hartung. Also used for this paper was the article “The risk of Guillain-Barre Syndrome after influenza vaccination” written by Mark P. Walberg, PharmD, PhD and the website http://emedicine.medscape.com/article/315632-overview These references go into detail about Guillain-Barre Syndrome from the pathophysiology to the causes and treatments. Guillain-Barre Syndrome is a disorder that attacks the peripheral nervous system. The disorder is abbreviated as GBS. GBS is also known as Guillain-Barre-Strohl syndrome, Landry’s paralysis, and acute inflammatory polyneuropathy.” http://emedicine.medscape.com/article/315632-overview” Because it is not currently clear if there is a disease-causing agent involved with Guillain-Barre it has been classified as a disorder, instead of a disease. GBS is an autoimmune disorder in that the body starts attacking itself. The pathophysiology of the disease starts when the myelin sheath of both the spinal and cranial nerves are demyelinated. Then the presence of lymphocytes and macrophages, which are inflammatory infiltrates, add fuel to the fire so to say. Lymphocytes infiltrate the spinal and cranial nerves and the macrophages demyelinate the myelin sheaths. The demyelination of the nerves causes axonal atrophy, whic... ... middle of paper ... ...sed to help patients with slow recovery or suffering severe disease. IVIG(Intravenous immunoglobulin) is a blood product administered intravenously. It contains the pooled, polyvalent, IgG antibodies extracted from the plasma of over one thousand blood donors. There is no known cure for Guillain-Barre syndrome. It is however treatable, with the majority of people making a full recovery. There are a number of different ways to treat the disease. Therapies include speech, respiratory physical, occupational and IVIG’s. Medications used to help treat GBS include low-molecular weight heparins such as Lovenox, Fragmin and Tinzaparin. These are used to treat the prophylaxis of deep venous thrombosis. Other medications include Tylenol, Ibuprofen, and Naproxen. These are used to treat pain associated with GBS (http://emedicine.medscape.com/article/315632-overview)
It was the beginning of February when my grandfather was going in to receive his second knee replacement. Being his second time, we were optimistic that the surgery would go well and that he would recover without any issues. My grandfather made it through surgery and accordingly, had to stay for observation. During this time everything appeared to be normal, and knowing that my grandfather hates to be in hospitals, wouldn’t have said otherwise. When he was finally discharged, we took him home and the next day he appeared to have a stroke. The left side of his face had drooped down and he began feeling numbness and tingling on both sides of his body. We immediately rushed him to the hospital and at first it was assumed it was a stroke, but as his illness progressed it was apparent it was not. The numbness soon led to the loss of muscle control beginning at his legs and rapidly spreading up. My grandfather was able to specifically describe what he was experiencing and the doctor was able to diagnose him with Guillain- Barré syndrome.
Lou Gehrig's disease is often referred to as Amyotrophic lateral sclerosis (ALS), this is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Motor neurons come from the brain to the spinal cord and from the spinal cord to the muscles throughout the entire body. The progressive degeneration of the motor neurons in ALS would eventually leads to their death. When the motor neurons die, the ability of the brain to initiate and control muscle movement is also lost. With voluntary muscle action progressively affected, for this reason patients in the later stages of the disease may become totally paralyzed (Choi, 1988).
research. All that was known is that Rasmussen’s encephalitis was a degenerative disease of the brain
Multiple sclerosis is a chronic inflammatory autoimmune disease of the central nervous system, directed against the myelin sheath. Leading to demyelination and axonal loss. It’s characterized by spread “plaques” of demielinization typically found in typically found on MRI in the periventricular region, corpus callosum, centrum semiovale and, to a lesser extent, deep white – structures and basal ganglia.(Olek, 2005)
affect several age groups. Children can develop GAD and suffer from it the rest of their lives.
Multiple sclerosis is a chronic disease of the central nervous system. It is understood as an autoimmune disease, a condition where the body’s immune system mistakenly attacks normal tissues. In Multiple Sclerosis, the patient’s own cells & antibodies attack the fatty myelin sheath that protects and insulates nerve fibres in the brain and spinal cord, the two components of the CNS. This ultimately causes damage to the nerve cells and without the insulation the myelin sheath provides, nerve communication is disrupted. Hence, Multiple Sclerosis is characterized by symptoms that reflect central nervous system involvement (Luzzio, 2014).
Multiple sclerosis was first discovered in 1868 by a neurologist by the name of Jean Martin- Charcot. Multiple sclerosis receives its name from the distinctive areas of scar tissue with the formation of damaged myelin sheaths. Multiple Sclerosis is referred to as an immune- mediated response that targets the central nervous system, including the spinal cord, the brain, and other parts of the body. The central nervous system is usually targeted by an abnormal response to the human body’s immune system causing an attack on the myelin coated fibers around nerve fibers. Generally, this occurs due to inflammation of myelin in the brain, causing lesions or plaques to form. Since myelin sheaths in the nervous system are there to increase nerve impulses,
Multiple sclerosis is an immune mediated disease, although many researchers argue it is an autoimmune disease. MS causes the body to create an abnormal immune response to the Central Nervous System (CNS). The CNS is the body’s processing center. It consists of the brain, spinal cord and peripheral nerves. The axon of these nerve cells are coated with a myelin sheath, a fatty substance that surrounds the nerve endings. This sheath protects and insulates the axons allowing electrical impulses to pass freely from one nerve cell to the next. MS causes the body’s immune system to produce T-cells that pass from the bloodstream and into the central nervous system. The T-cells directly attack the nerve cells as if they were a foreign substance. They destroy the myelin coating around nerve fibers. When any part of the myelin is damaged scar tissue forms around the nerve ending. This demyelination and scaring causes lesions on the nerves. The lesions prevent impulses from traveling throughout the body and hinders the body’s response to afferent and efferent signals being sent to and from the brain.
Why does this self-inflicted deconstruction of the myelin occur? Multiple sclerosis is said to have genetic and environmental factors to its cause. Malnutrition and free radicals can all trigger a dormant M.S. gene in a person. According to the National Multiple Sclerosis Society, What Causes MS, studies say that “Growing evidence suggests that vitamin D plays an important role. People who live closer to the equator are exposed to greater amounts of sunlight year-round. As a result, they tend to have higher levels of naturally-produced vitamin D.” In fact, vitamin D holds specific immune strengthening qualities. Make it a priority to remain nourished, keeping your immune system at optimal strength, thus preventing pos...
Rousmaniere, Peter. “Facing a tough situation.” Risk & Insurance 17.7 (June 2006): 24-25. Expanded Academic ASAP. Web. 23 March 2011.
Guillain- Barre Syndrome (GBS) is a rare, but very fatal auto- immune disease that specifically focuses on attacking the myelin sheath that surrounds the peripheral nerves in the human body. There are many different severities of this disease, but without treatment it can not only affect the entire nervous system but eventually shut down the rest of the body.
Because CJD is such a rapid progressing disease most patients die within one year of onset. Some of the symptoms associated with CJD are much like Alzheimer’s. “Some common symptoms include depression, agitation, apathy and mood swings, rapidly worsening confusion, disorientation and problems with memory, thinking, planning and judgement, difficulty walking, and muscle stiffness, twitches, and involuntary movements.” (Alzheimer's Association, 2016). Diagnosis of CJD is a controversial issue. The only way to diagnose CJD is by brain biopsy or autopsy. In a brain biopsy, a small piece of tissue is removed and examined by a neuropathologist. This is of course dangerous and not always effective because it is hard to know if the tissue obtained is from the affected part of the brain. Biopsies are usually not recommended, not only because of the risk, but because there is no treatment available that will cure CJD. “There is no treatment that can slow or stop the underlying brain cell destruction caused by Creutzfeldt-Jakob disease and other prion diseases. Various drugs have been tested but have not shown any benefit. Clinical studies of potential CJD treatments are complicated by the rarity of the disease and its rapid progression.” (Alzheimer's Association, 2016). Treatment for CJD is aimed at alleviating symptoms and making the patient as comfortable as possible. “Doctors may prescribe painkillers such as opiates to treat pain if it occurs. Muscle stiffness and twitching may be treated with muscle-relaxing medications or antiseizure drugs. In the later stages of the disease, individuals with CJD become completely dependent on others for their daily needs and comfort.” (Alzheimer's Association,
Multiple sclerosis (MS) is an acquired demyelinating disease of the central nervous system (CNS) that typically is diagnosed in the second or third decade of life. Normally, nerves are enclosed in myelin sheaths that help facilitate transmission of nerve impulses within the CNS and the peripheral nervous system throughout the body. In patients with MS, the myelin sheath is damaged and eventually degenerates, causing patches of scar tissue called plaques or lesions to occur anywhere randomly on the myelin sheath (Ruto, 2013). This results in impaired nerve conductivity, which interferes with message transmission between the brain and the other parts of the body. As a result, impulse transmission is altered, distorted, short-circuited, or completely absent. This interference in impulse transmission creates muscle weakness, muscle imbalance, and possibly muscle spasms with partial or complete paralysis. Multiple sclerosis also can result in visual impairment and alteration of cognitive abilities, as well as pain, numbness, or tingling sensations (Ruto, 2013).
Grossman, S.J and Hart, O.D (1983). An Analysis of the Principal-Agent Problem. Econometrica Vol. 51, No. 1 January 1983. Available on: http://classes.maxwell.syr.edu/ecn611/GrossmanHart83.pdf. [Accessed on 20th of April 2014].
As has been discussed before, risk identification plays an important part in the risk such as unique, subjective, complex and uncertainly. There are no two identical leaves in the world; similar, there are no two exactly the same risk either. Hence the best risk manger could not identify risk completely. Besides, risk identification assessment is done by risk analysts. As the different level of risk management knowledge, practical experience and other aspects between individuals, the result of risk identification may be difference. Furthermore, the process of identifying risk is still risky. Once risks have been identified, corporations have to take actions on limiting risky actions to reduce the frequency and severity of risky. They have to think about any lost profit from limiting distribution of risky action. So reducing risk identification risk is one of assessments in the risk